The Role of Trace Metals in the Development and Progression of Prostate Cancer
View abstract on PubMed
Summary
This summary is machine-generated.Trace metals like zinc and selenium are linked to prostate cancer (PCa) development. This review explores how these metals impact PCa biology at a molecular level, guiding future research directions.
Area Of Science
- Oncology
- Environmental Health
- Molecular Biology
Background
- Prostate cancer (PCa) has a complex etiology involving genetic, environmental, and lifestyle factors.
- Trace metals are increasingly recognized for their potential association with PCa development and progression.
- Specific metals like zinc (Zn), selenium (Se), cadmium (Cd), and arsenic (As) are under scrutiny for their role.
Purpose Of The Study
- To review and synthesize current knowledge on the influence of trace metals on prostate cancer.
- To analyze the molecular mechanisms by which trace metals affect prostate cancer biology.
- To identify gaps in research and suggest future research directions.
Main Methods
- Comprehensive literature review of recent studies on trace metals and prostate cancer.
- Integration of findings related to genomics, epigenetics, proteomics, and transcriptomics.
- Analysis of molecular-level impacts of trace metals on prostate cancer.
Main Results
- Trace metals can modulate prostate cancer risk and progression through various molecular pathways.
- Specific metals have demonstrated roles in influencing cancer omics.
- Evidence suggests a direct link between certain trace metal exposures and PCa biology.
Conclusions
- Trace metals play a significant role in the molecular biology of prostate cancer.
- Further research is needed to fully elucidate the mechanisms and therapeutic implications.
- Understanding these interactions can inform preventative strategies and treatment approaches for PCa.
Related Concept Videos
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...

